Skip to main content

Table 1 Abbreviated clinical summary of patients with pathogenic variants in IARS2

From: Expanding the clinical phenotype of IARS2-related mitochondrial disease

 

Patient 1 (Present study)

Patient 2 (Present study)

Patient 3 (Present study)

Patient 4 Takezawa et al., 2018 [9]

Patient 5 Takezawa et al., 2018 [9]

Patient 6 Moosa et al., 2017 [7]

Patient 7 (Case 1 in Schwartzentruber et al., 2014 [5]; Jabbour and Harissi-Dagher, 2016 [29]

Patient 8 Case 2 in Schwartzentruber et al., 2014 [5] Patient 1 Liberfarb et al., 1993 [6]

Patient 9 Case 3 in Schwartzentruber et al., 2014 [5] Patient 2 Liberfarb et al., 1993 [6]

Patient 10 Case 4 in Schwartzentruber et al., 2014 [5]

Ethnic descent

Iranian

Iranian

Iranian

Japanese

Japanese

Danish

French-Canadian

French-Canadian

French-Canadian

Scandinavian-Caucasian

Sex

Male

Female

Female

Female

Female

Female

Female

Male

Female

Male

Age at publication

20.6 years

35 years

27 years

8 years

5 years

8 years

33 years

6 years

16.5 years

18 months

Genotype

c.2725C > T p.Pro909Ser

c.2282A > G p.His761Arg

c.2282A > G p.His761Arg

c.680 T > C, p.Phe227Ser; c.2450G > A, p.Arg817His

c.680 T > C, p.Phe227Ser; c.2450G > A, p.Arg817His

c.2620G > A p.Gly874Arg

c.2726C > T p.Pro909Leu

c.2726C > T p.Pro909Leu

c.2726C > T, p.Pro909Leu

c.1821G > A p.Trp607*; c.2122G > A p.Glu708Lys

Ocular evaluation

 Bilateral nystagmus

Yes

Yes

Yes

–

–

Yes

Yes, at 1 month

Yes, at 5 months

Yes, 3 months

–

 Cataract

Yes, at birth

Yes, at birth

Yes, at birth

Yes, at birth

–

Yes, at 3 years

Yes, at 17 months; cataract extraction at 22 months

Yes, at 5 months; cataract extraction at 7 months

Yes, 3 months; cataract extracted at 13 months

–

 Corneal opacification

Yes

Yes

Yes

–

–

–

Yes, at 5 years, progressive

Yes, at 5 years

Yes, at 16 years 5 months

–

Endocrinology

 Endocrine disturbances

Central adrenal insufficiency, growth hormone deficiency

–

–

–

–

–

Adrenal insufficiency, growth hormone deficiency

–

–

–

 Growth hormone replacement therapy

–

–

–

–

–

–

Yes, positive outcome

Yes, positive outcome (cortisol deficiency)

–

–

 Hypoglycemic Episodes

–

–

–

–

–

–

Yes

–

Yes

Yes

Auditory evaluation

 Hearing loss

Moderate bilateral sensorineural hearing loss at 13 years of age

–

–

–

–

Bilateral sensorineural hearing loss at 8 years old

Bilateral sensorineural stable hearing loss at 2 years old

Moderate bilateral sensorineural hearing loss at 21 months

–

–

Gastroenterology

 Type II esophageal Achalasia

Yes, from birth

–

–

–

–

–

Yes, 32 years

–

–

–

Musculoskeletal

 Short stature

Yes, proportionate (−3.4 SD)

Yes

Yes

Yes

Yes

Yes, disproportionate (−6 SD),

Yes, disproportionate

Yes

Yes

–

 Hip dislocation

–

–

–

–

–

Yes, at birth

Yes, at 2 years

Yes, at birth

Yes, at 18 months

–

Spine abnormalities

Yes, mild scoliosis

–

–

Yes

Yes

Yes, abnormal vertebral bodies

Yes, mild scoliosis

Yes, scoliosis

Yes, scoliosis

 

 Spondylo-epi-meta- physeal dysplasia

Yes

Yes, disproportional shortening of the first metacarpal reduced bone density

Yes, disproportional shortening of the first metacarpal

–

–

Yes

Yes

Yes

Yes

–

Neurological and Developmental Assessment

 Leigh syndrome features

–

–

–

Yes

Yes

–

–

–

–

Yes

 West syndrome

–

–

–

Yes

Yes

–

–

–

–

–

 Neurodevelopmental Delay

Yes

–

–

Yes

Yes

Yes

Yes, mild

Yes

Yes

Yes

 Current normal Intelligence

Yes

Yes

Yes

–

–

Yes

Yes

–

Yes

?

 Peripheral neuropathy

Chronic sensorimotor distal axonal polyneuropathy

–

–

–

–

Yes, pain insensitivity in early childhood

Yes, at 9.5 years

Yes, in early childhood

Yes, at 8 months

–